CAMP4 Therapeutics Corporation (CAMP) Insider Trading Activity

NASDAQ$3.78-0.05 (-1.31%)
Market Cap
$240.34M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
294 of 849
Rank in Industry
167 of 491

CAMP Insider Trading Activity

CAMP Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$99,051
5
45
Sells
$2,504,037
6
55

Related Transactions

Gold KellyChief Financial Officer
2
$50,409
0
$0
$50,409
Young Richard Adirector
1
$27,024
0
$0
$27,024
Mandel-Brehm JoshChief Executive Officer
1
$10,809
0
$0
$10,809
Maricich YuriChief Medical Officer
1
$10,809
0
$0
$10,809
Tardiff DanielChief Scientific Officer
0
$0
1
$8,273
$-8,273
Schwab Andrew J.director
0
$0
5
$2.5M
$-2.5M

About CAMP4 Therapeutics Corporation

CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.

Insider Activity of CAMP4 Therapeutics Corporation

Over the last 12 months, insiders at CAMP4 Therapeutics Corporation have bought $99,051 and sold $2.5M worth of CAMP4 Therapeutics Corporation stock.

On average, over the past 5 years, insiders at CAMP4 Therapeutics Corporation have bought $4.64M and sold $1.26M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Gold Kelly (Chief Financial Officer) — $50,409. Young Richard A (director) — $27,024. Mandel-Brehm Josh (Chief Executive Officer) — $10,809.

The last purchase of 10,000 shares for transaction amount of $39,600 was made by Gold Kelly (Chief Financial Officer) on 2026‑08‑31.

List of Insider Buy and Sell Transactions, CAMP4 Therapeutics Corporation

2026-08-31PurchaseGold KellyChief Financial Officer
10,000
0.0173%
$3.96
$39,600
-3.03%
2026-08-27SaleSchwab Andrew J.director
400,000
0.6738%
$4.04
$1.62M
-7.00%
2026-08-24SaleSchwab Andrew J.director
10
<0.0001%
$4.50
$45
-10.19%
2026-08-21SaleSchwab Andrew J.director
32,018
0.1514%
$4.50
$144,081
-12.95%
2026-08-20SaleSchwab Andrew J.director
114,700
0.5497%
$4.54
$520,738
-12.44%
2026-08-19SaleSchwab Andrew J.director
45,147
0.2176%
$4.76
$214,900
-15.91%
2026-08-19SaleTardiff DanielChief Scientific Officer
1,738
0.0084%
$4.76
$8,273
-15.91%
2026-08-03PurchaseMandel-Brehm JoshChief Executive Officer
6,551
0.0044%
$1.65
$10,809
-4.75%
2026-08-03PurchaseYoung Richard Adirector
16,378
0.0111%
$1.65
$27,024
-4.75%
2026-08-03PurchaseGold KellyChief Financial Officer
6,551
0.0044%
$1.65
$10,809
-4.75%
2026-08-03PurchaseMaricich YuriChief Medical Officer
6,551
0.0044%
$1.65
$10,809
-4.75%
2025-09-11Purchase5AM Partners VI, LLC10 percent owner
2.94M
8.0289%
$1.53
$4.5M
+52.52%
2025-09-11PurchasePolaris Management Co. VII, L.L.C.10 percent owner
1.31M
3.5684%
$1.53
$2M
+52.52%
2025-09-11PurchaseNashat Amir
1.31M
3.5684%
$1.53
$2M
+52.52%
2025-09-11PurchaseMandel-Brehm JoshChief Executive Officer
6,060
0.0178%
$1.65
$9,999
+52.52%
2025-09-11PurchaseYoung Richard Adirector
15,151
0.0446%
$1.65
$24,999
+52.52%
2025-09-11PurchaseGold KellyChief Financial Officer
6,060
0.0178%
$1.65
$9,999
+52.52%
2025-09-11PurchaseMaricich YuriChief Medical Officer
6,060
0.0178%
$1.65
$9,999
+52.52%
2024-06-05SaleCohenour Jasondirector
8,640
0.5356%
$0.83
$7,176
+478.37%
2023-01-27PurchaseCummins Wesdirector
25,000
0.069%
$4.52
$112,970
-80.57%
Total: 368
*Gray background shows transactions not older than one year

Insider Historical Profitability

52.52%
Mandel-Brehm JoshChief Executive Officer
284968
0.4541%
$1.09M20
+52.52%
Young Richard Adirector
186388
0.297%
$713,866.0420
+52.52%
Maricich YuriChief Medical Officer
12611
0.0201%
$48,300.1320
+52.52%
Gold KellyChief Financial Officer
10000
0.0159%
$38,300.0030
+52.52%
Cummins Wesdirector
3424059
5.4564%
$13.11M210
5AM Partners VI, LLC10 percent owner
2941176
4.6869%
$11.26M10
+52.52%
Nashat Amir
2825500
4.5026%
$10.82M10
+52.52%
Polaris Management Co. VII, L.L.C.10 percent owner
2825500
4.5026%
$10.82M10
+52.52%
B. Riley Asset Management, LLC
2229159
3.5523%
$8.54M60
Burdiek Michael JPresident & CEO
615020
0.9801%
$2.36M1135
GARDNER JEFFERY RPresident & CEO
487971
0.7776%
$1.87M210
GOLD RICHARD Bdirector
385439
0.6142%
$1.48M4712
VITELLE RICHARD KExecutive VP & CFO
249211
0.3971%
$954,478.131646
PERNA FRANK JRdirector
224722
0.3581%
$860,685.262817
Sarkissian Garo SarkisSVP Corporate Development
178876
0.285%
$685,095.08523
BINDER KURTIS JOSEPHChief Financial Officer
177718
0.2832%
$680,659.9410
WOLFE LARRY Jdirector
171275
0.2729%
$655,983.25112
STURM FRED MPresident & CEO
160000
0.255%
$612,800.0042
PARDUN THOMAS Edirector
119345
0.1902%
$457,091.35162
Johnson Amal Mdirector
97049
0.1547%
$371,697.6740
MOYER ALBERT Jdirector
88676
0.1413%
$339,629.0812
Alexy Kimberlydirector
47729
0.0761%
$182,802.0726
HUTCHINS PATRICKPresident, Satellite Division
39750
0.0633%
$152,242.5030
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$22,710,871
107
8.53%
$220.62M
$6,146,922
96
-4.70%
$233.68M
$60,836,085
69
0.45%
$255.44M
$19,239,249
50
-2.24%
$238.33M
$168,352,523
35
13.58%
$218.79M

CAMP Institutional Investors: Active Positions

Increased Positions24+80%12M+40.9%
Decreased Positions12-40%2M-5.32%
New Positions13New5MNew
Sold Out Positions2Sold Out653,599Sold Out
Total Postitions42+40%38M+35.58%

CAMP Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
5Am Venture Management, Llc$35,215.0011.29%5.87M+3M+100.45%2025-09-30
Janus Henderson Group Plc$27,846.008.93%4.64M+5MNew2025-09-30
Vivo Capital, Llc$23,529.007.54%3.92M+4MNew2025-09-30
Enavate Sciences Gp, Llc$22,715.007.28%3.79M00%2025-09-30
Fmr Llc$18,141.005.81%3.02M+2M+397.32%2025-09-30
A16z Capital Management, L.L.C.$12,752.004.09%2.13M00%2025-09-30
Adage Capital Partners Gp, L.L.C.$11,765.003.77%1.96M+2MNew2025-09-30
Harbourvest Partners Llc$7,632.002.45%1.27M00%2025-09-30
Silverarc Capital Management, Llc$3,922.001.26%653,594+653,594New2025-09-30
Vanguard Group Inc$1,881.000.6%313,506-15,385-4.68%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.